AU8465701A - Use of vitamin d derivatives as bone resorption inhibitors - Google Patents

Use of vitamin d derivatives as bone resorption inhibitors

Info

Publication number
AU8465701A
AU8465701A AU8465701A AU8465701A AU8465701A AU 8465701 A AU8465701 A AU 8465701A AU 8465701 A AU8465701 A AU 8465701A AU 8465701 A AU8465701 A AU 8465701A AU 8465701 A AU8465701 A AU 8465701A
Authority
AU
Australia
Prior art keywords
vitamin
derivatives
bone resorption
resorption inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8465701A
Inventor
Seiichi Ishizuka
Kazuya Takenouchi
Atsushi Imaizumi
Yasuhiro Oue
Noriyoshi Kurihara
Sakamuri V Reddy
G David Roodman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
UT Health Science Center at San Antonio
Original Assignee
Teijin Ltd
UT Health Science Center at San Antonio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, UT Health Science Center at San Antonio filed Critical Teijin Ltd
Publication of AU8465701A publication Critical patent/AU8465701A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
AU8465701A 2000-08-23 2001-08-22 Use of vitamin d derivatives as bone resorption inhibitors Pending AU8465701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000252177A JP2002069003A (en) 2000-08-23 2000-08-23 Deossification inhibitor containing vitamin d derivative
PCT/US2001/022614 WO2002015894A2 (en) 2000-08-23 2001-08-22 Use of vitamin d derivatives as bone resorption inhibitors

Publications (1)

Publication Number Publication Date
AU8465701A true AU8465701A (en) 2002-03-04

Family

ID=18741464

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001284657A Ceased AU2001284657B2 (en) 2000-08-23 2001-08-22 Use of vitamin d derivatives as bone resorption inhibitors
AU8465701A Pending AU8465701A (en) 2000-08-23 2001-08-22 Use of vitamin d derivatives as bone resorption inhibitors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001284657A Ceased AU2001284657B2 (en) 2000-08-23 2001-08-22 Use of vitamin d derivatives as bone resorption inhibitors

Country Status (7)

Country Link
EP (1) EP1311253A2 (en)
JP (1) JP2002069003A (en)
AU (2) AU2001284657B2 (en)
CA (1) CA2420274A1 (en)
NO (1) NO20030820L (en)
NZ (1) NZ524305A (en)
WO (1) WO2002015894A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040096589A (en) * 2002-02-20 2004-11-16 데이진 가부시키가이샤 Vitamin d3 derivatives and remedies using the same
EP1342796A3 (en) * 2002-02-22 2004-01-02 Teijin Limited Compound for the treatment of paget's disease of bone
KR101092277B1 (en) * 2003-01-30 2011-12-13 데이진 화-마 가부시키가이샤 Vitamin ?3 lactone derivative
CA2544725A1 (en) * 2003-11-04 2005-05-12 Teijin Pharma Limited Vitamin d3 lactam derivative
US7524980B2 (en) 2003-11-04 2009-04-28 Teijin Pharma Limited Vitamin D3 lactam derivative
JP2007070281A (en) * 2005-09-06 2007-03-22 Matsumoto Shika Univ Remedy for osteoporosis produced by using retinoid x receptor-relating compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631025B1 (en) * 1988-05-04 1991-04-12 Ire Medgenix Sa NOVEL VITAMIN D3 DERIVATIVES AND APPLICATION TO DETERMINATIONS OF VITAMIN D3 METABOLITES
DE19744127B4 (en) * 1997-10-01 2006-10-05 Schering Ag New vitamin D derivatives with side-chain cyclopropyl rings, processes and intermediates for their preparation and their use in the manufacture of medicaments
CA2348235A1 (en) * 1998-10-23 2000-05-04 Teijin Limited Vitamin d3 derivatives and treating agent for inflammatory respiratory disease using same

Also Published As

Publication number Publication date
AU2001284657B2 (en) 2006-01-19
WO2002015894A3 (en) 2002-08-29
EP1311253A2 (en) 2003-05-21
NO20030820D0 (en) 2003-02-21
JP2002069003A (en) 2002-03-08
NZ524305A (en) 2004-08-27
WO2002015894A2 (en) 2002-02-28
NO20030820L (en) 2003-04-22
CA2420274A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
HK1061854A1 (en) Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
SI1686119T1 (en) Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
PL363603A1 (en) Fumaric acid derivatives as nf-kappab inhibitors
IL157282A0 (en) Pyrimidine derivatives for inhibition of cell-proliferation
GB0025782D0 (en) Use of inhibitors
HK1091492A1 (en) Hydantoin derivatives as mmp inhibitors
AU2002357882A8 (en) Small-molecule inhibitors of interleukin-2
HUP0300061A3 (en) Use of il-18 inhibitors
PL357780A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
IL146409A0 (en) Furanone derivatives as inhibitors of cathepsin s
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2003214609A8 (en) Derivatives of isoflavones
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
AU8465701A (en) Use of vitamin d derivatives as bone resorption inhibitors
HRP20020970A2 (en) 2-aminothiazoline derivatives and their use as no-synthase inhibitors
AU2001245092A1 (en) Sterilization of elongate lumens
AU2002305868A1 (en) Inhibitors of reggamma
HK1053059A1 (en) New use of imidazotriazinon derivatives
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
EP1430302A4 (en) Inhibitors of glycosaminoglycans
AU2001218028A1 (en) Sterilization of elongate lumens
GB0109520D0 (en) Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors